Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (221-230 of 755) with videos related to

Pageof 76
Sort By:
Clinical and Experimental Rheumatology|September 5, 2015
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?Yolanda Braun-Moscovici, Marius Braun, Dinesh Khanna, et al.
Journal of Scleroderma and Related Disorders|March 2, 2018
Systemic Sclerosis Trial Design Moving ForwardSindhu R Johnson, Dinesh Khanna, Yannick Allanore, et al.
Environmental Science & Technology|September 25, 2019
Disinfection Byproducts in Rajasthan, India: Are Trihalomethanes a Sufficient Indicator of Disinfection Byproduct Exposure in Low-Income Countries?Kirin E Furst, Rachel M Coyte, Margaret Wood, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider in renal involvement in systemic sclerosisFelice Galluccio, Ulf Müller-Ladner, Daniel E Furst, et al.
Clinical and Experimental Rheumatology|November 6, 2014
A cautionary tale: dealing with missing data in clinical trials for rheumatic diseasesJ Song, W J Boscardin, D E Furst, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1990
CO2 power-assisted hand-held syringe: better visualization during diagnostic and interventional angiographyR A Krieger, A E Furst, F J Hildner, et al.
International Journal of Rheumatology|October 12, 2010
An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary ResultsMarie Hudson, Murray Baron, Ernest Lo, et al.
Nature Reviews. Nephrology|September 20, 2016
Scleroderma renal crisis and renal involvement in systemic sclerosisThasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
The Journal of Rheumatology|March 3, 2012
Epidemiology of systemic sclerosis in a large US managed care populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
RMD Open|November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritisMichael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Pageof 76

Showing results (221-230 of 755) with videos related to

Sort By:
Pageof 76
Clinical and Experimental Rheumatology|September 5, 2015
What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?Yolanda Braun-Moscovici, Marius Braun, Dinesh Khanna, et al.
Journal of Scleroderma and Related Disorders|March 2, 2018
Systemic Sclerosis Trial Design Moving ForwardSindhu R Johnson, Dinesh Khanna, Yannick Allanore, et al.
Environmental Science & Technology|September 25, 2019
Disinfection Byproducts in Rajasthan, India: Are Trihalomethanes a Sufficient Indicator of Disinfection Byproduct Exposure in Low-Income Countries?Kirin E Furst, Rachel M Coyte, Margaret Wood, et al.
Rheumatology (Oxford, England)|October 10, 2017
Points to consider in renal involvement in systemic sclerosisFelice Galluccio, Ulf Müller-Ladner, Daniel E Furst, et al.
Clinical and Experimental Rheumatology|November 6, 2014
A cautionary tale: dealing with missing data in clinical trials for rheumatic diseasesJ Song, W J Boscardin, D E Furst, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1990
CO2 power-assisted hand-held syringe: better visualization during diagnostic and interventional angiographyR A Krieger, A E Furst, F J Hildner, et al.
International Journal of Rheumatology|October 12, 2010
An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary ResultsMarie Hudson, Murray Baron, Ernest Lo, et al.
Nature Reviews. Nephrology|September 20, 2016
Scleroderma renal crisis and renal involvement in systemic sclerosisThasia G Woodworth, Yossra A Suliman, Wendi Li, et al.
The Journal of Rheumatology|March 3, 2012
Epidemiology of systemic sclerosis in a large US managed care populationDaniel E Furst, Ancilla W Fernandes, Serban R Iorga, et al.
RMD Open|November 5, 2015
Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritisMichael Nurmohamed, Yanjun Bao, James Signorovitch, et al.
Pageof 76